The thyroid hormone receptor β (TRβ) gene generates two different proteins by use of a different promoter (β1 and β2). We now report a novel short TRβ1 RNA splice variant in humans lacking 35 nucleotides at the 3’ end of the noncoding exon 1 due to an alternative 5’ splice donor site. This short variant was first identified in sequences of cDNA obtained from cultured human fibroblasts. Both variants were found in human fibroblasts, brain, pituitary, adrenal gland, placenta, muscle, thyroid and lymphocytes. These TRβ1 variants possess splice donor sites with a sequence score slightly favoring the TRβ1 long variant. Variant-specific real-time polymerase chain reaction (PCR) showed that their relative proportions were equal except in pituitary and muscle, in which the long form was 3- and 5-fold in excess. T3 treatment of fibroblasts grown in thyroid hormone depleted medium did not affect the absolute or relative expression of the two variants. Furthermore, the expression level in fibroblasts from patients with resistance to thyroid hormone with or without TRβ gene mutations was not different to that in fibroblasts from normal controls.

A novel splice variant involving the 5’ untranslated region of thyroid hormone receptor beta1 (TRbeta1) / D. Mannavola, L.C. Moeller, P. Beck-Peccoz, L. Persani, R.E. Weiss, S. Refetoff. - In: JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. - ISSN 0391-4097. - 27:4(2004), pp. 318-322.

A novel splice variant involving the 5’ untranslated region of thyroid hormone receptor beta1 (TRbeta1)

D. Mannavola
Primo
;
P. Beck-Peccoz;L. Persani;
2004

Abstract

The thyroid hormone receptor β (TRβ) gene generates two different proteins by use of a different promoter (β1 and β2). We now report a novel short TRβ1 RNA splice variant in humans lacking 35 nucleotides at the 3’ end of the noncoding exon 1 due to an alternative 5’ splice donor site. This short variant was first identified in sequences of cDNA obtained from cultured human fibroblasts. Both variants were found in human fibroblasts, brain, pituitary, adrenal gland, placenta, muscle, thyroid and lymphocytes. These TRβ1 variants possess splice donor sites with a sequence score slightly favoring the TRβ1 long variant. Variant-specific real-time polymerase chain reaction (PCR) showed that their relative proportions were equal except in pituitary and muscle, in which the long form was 3- and 5-fold in excess. T3 treatment of fibroblasts grown in thyroid hormone depleted medium did not affect the absolute or relative expression of the two variants. Furthermore, the expression level in fibroblasts from patients with resistance to thyroid hormone with or without TRβ gene mutations was not different to that in fibroblasts from normal controls.
Recettore beta della T3 ; RNA splicing ; Real time PCR ; Resistenza alla T3
Settore MED/13 - Endocrinologia
2004
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/5907
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 4
social impact